Cargando…
Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice
Antigen-based therapies (ABTs) very effectively prevent the development of type 1 diabetes (T1D) when given to young nonobese diabetic (NOD) mice, however, they have little or no ability to reverse hyperglycemia in newly diabetic NOD mice. More importantly, ABTs have not yet demonstrated an ability...
Autores principales: | Tian, Jide, Dang, Hoa, Kaufman, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178649/ https://www.ncbi.nlm.nih.gov/pubmed/21966502 http://dx.doi.org/10.1371/journal.pone.0025337 |
Ejemplares similares
-
Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2014) -
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
por: Tian, Jide, et al.
Publicado: (2017) -
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T Cells
por: Tian, Jide, et al.
Publicado: (2019) -
Increased risk for T cell autoreactivity to ß-cell antigens in the mice expressing the A(vy) obesity-associated gene
por: Yong, Jing, et al.
Publicado: (2019) -
GABA(B)-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice
por: Tian, Jide, et al.
Publicado: (2021)